Grassley Requests FDA Info On Guidant ICD Alerts Following NEJM Article
This article was originally published in The Gray Sheet
Executive Summary
Senate Finance Committee Chair Chuck Grassley (R-Iowa) is asking FDA for a detailed briefing on the "regulatory history" of Guidant's Ventak Prizm 2 DR ICD and the agency's plans to address medical device safety issues
You may also be interested in...
CDRH 2006 Priorities Reflect Urgency Of Device Postmarket Issues
CDRH's fiscal year 2006 priorities highlight the pressing need to address postmarket device safety concerns following the string of cardiac rhythm management product recalls this summer